Coronavirus: Fact vs Fiction   /     The Big Business Behind Weight Loss Drugs

Description

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little context about the business behind these new medications. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Subtitle
Duration
1989
Publishing date
2024-02-06 09:00
Contributors
  CNN
author  
Enclosures
https://www.podtrac.com/pts/redirect.mp3/pdst.fm/e/chrt.fm/track/E31CC9/traffic.megaphone.fm/WMHY4379240139.mp3?updated=1707190933
audio/mpeg

Shownotes

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little context about the business behind these new medications.

Learn more about your ad choices. Visit podcastchoices.com/adchoices